Back to Search Results

Cost effectiveness of once-daily oral chelation therapy with deferasirox versus infusional deferoxamine in transfusion-dependent thalassaemia patients: US healthcare system perspective

Policy Analysis Inc. (PAI), Brookline, Massachusetts 02445, USA. tdelea@pai2.com

Pharmacoeconomics. 2007;25((4):):329-42.
Full text from:

Other resources

Study details
Study Design : Economic Study
Credits : Bibliographic data from MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine